AGP Executive Report
Last update: 9 hours agoBerberine “natural Ozempic” myth checked: A new review in International Journal of Molecular Sciences says berberine likely works indirectly via gut inflammation, the intestinal barrier and microbiome changes—not like GLP-1 drugs. It also flags big person-to-person differences and possible digestive side effects and drug interactions. Sugar-sweetener reassurance: EFSA re-evaluated aspartame-acesulfame salt (E962) and says current exposure levels don’t raise safety concerns, with ADIs still below limits. School nutrition in focus: Ireland’s school milk scheme is revisited as new reporting highlights low dairy and vitamin D intake among teens, raising concerns for bone development. Food policy pressure in India: Reuters reports India may introduce tougher “red warning” labels for foods high in sugar, salt or saturated fat, as diabetes rates climb. Heat and heart health: A study in the European Heart Journal links light exposure during sleep to heart remodeling, while Copernicus says August was the hottest month on record. Public procurement with health in mind: A Swedish watchdog warns EU procurement reforms may not fully lock in human rights and environmental safeguards, even as quality weighting rises.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
